|
|
Books > Medicine > Other branches of medicine > Psychiatry
How are behavioral scientists increasingly involved to advise
global decision-makers in the United Nations and elsewhere?" In
2020, the Psychology Coalition at the United Nations (PCUN)
launched a bold new series of books, describing how evidence-based
behavioral research is increasingly used by United Nations and
other decision-makers, to address global issues. These issues
reflect the UN's 17 Sustainable Development Goals (SDGs) for
2030-such as health, poverty, education, peace, gender equality,
and climate change. This PCUN volume brings together 37 experts in
14 concise chapters, to focus on health in two parts: (1) a
data-based overview of diverse trends in global health-such as
COVID, opioids, dementia, and disabilities. (2) An examination of
underlying issues in global health-such as race, gender, LGBTQ+,
and health disparities (detailed below). The chapters are
co-authored by leading global experts as well as "rising star"
students from many nations--offering readers a concise overview of
each topic, a glossary of key terms, study questions, and
bibliography. This volume is suitable as a textbook for diverse
courses in psychology, social work, cross-cultural and
international studies.
In this issue, guest editors bring their considerable expertise to
this important topic. Provides in-depth reviews on the latest
updates in the field, providing actionable insights for clinical
practice. Presents the latest information on this timely, focused
topic under the leadership of experienced editors in the field.
Authors synthesize and distill the latest research and practice
guidelines to create these timely topic-based reviews.
A humane behind-the-scenes account of a week in the life of a
psychiatrist at one of Canada's leading mental health hospitals.
How Can I Help? takes us to the frontlines of modern psychiatric
care. How Can I Help? portrays a week in the life of Dr. David
Goldbloom as he treats patients, communicates with families, and
trains staff at CAMH, the largest psychiatric facility in Canada.
This highly readable and touching behind-the-scenes account of his
daily encounters with a wide range of psychiatric concerns--from
his own patients and their families to Emergency Department
arrivals--puts a human face on an often misunderstood area of
medical expertise. From schizophrenia and borderline personality
disorder to post-traumatic stress syndrome and autism, How Can I
Help? investigates a range of mental issues. What is it like to
work as a psychiatrist now? What are the rewards and challenges?
What is the impact of the suffering--and the recovery--of people
with mental illness on families and the clinicians who treat them?
What does the future hold for psychiatric care? How Can I Help?
demystifies a profession that has undergone profound change over
the past twenty-five years, a profession that is often
misunderstood by the public and the media, and even by doctors
themselves. It offers a compassionate, realistic picture of a
branch of medicine that is entering a new phase, as increasingly we
are able to decode the mysteries of the brain and offer new hope
for sufferers of mental illness.
The third edition of Psychiatric Rehabilitation, discusses
interventions to help individuals with mental illness improve the
quality of their life, achieve goals, and increase opportunities
for community integration so they can lead full and productive
lives. This person centered approach emphasizes strengths, skill
development, and the attainment of valued social roles. The third
edition has been fully updated with new coverage indicating how to
address medical problems while treating for mental illness,
wellness and recovery, evidence based practices, and directions for
future research. Retaining the easy to read, engaging style, each
chapter includes key terms with definitions, case studies, profiles
of leaders in the field, special issues relating to treatment and
ethics, and class exercises. Providing a comprehensive overview of
this growing field, the book is suitable as an undergraduate or
graduate textbook, as well as a reference for practitioners and
academic researchers. Special Features: Provides new coverage on
comorbid medical disorders, evidence based practices, wellness and
recovery, and direction for future research Identifies
controversial issues relating to treatment and ethics Supplies case
study examples to illustrate chapter points Highlights key terms
with definitions and key topics Offers focus questions and class
exercises as a teaching tool
Stress: Concepts, Cognition, Emotion, and Behavior: Handbook in
Stress Series, Volume 1, examines stress and its management in the
workplace and is targeted at scientific and clinical researchers in
biomedicine, psychology, and some aspects of the social sciences.
The audience is appropriate faculty and graduate and undergraduate
students interested in stress and its consequences. The format
allows access to specific self-contained stress subsections without
the need to purchase the whole nine volume Stress handbook series.
This makes the publication much more affordable than the previously
published four volume Encyclopedia of Stress (Elsevier 2007) in
which stress subsections were arranged alphabetically and therefore
required purchase of the whole work. This feature will be of
special significance for individual scientists and clinicians, as
well as laboratories. In this first volume of the series, the
primary focus will be on general stress concepts as well as the
areas of cognition, emotion, and behavior.
Developing Therapeutics for Alzheimer's Disease: Progress and
Challenges provides a thorough overview of the latest advances
toward the development of therapeutics for Alzheimer's disease,
along with the major hurdles that still must be overcome and
potential solutions to these problems. Despite the lack of progress
toward developing therapeutics that can slow or stop the
progression of this disease, important discoveries have been made
and many promising approaches are advancing in preclinical studies
and clinical trials. This book outlines the special challenges
related to specific targets and approaches, while presenting a
realistic, comprehensive and balanced view of drug discovery and
development in this area. Written by international leaders in the
field, the book assesses prospects for the emergence of effective
agents and allows readers to better understand the challenges,
failures, and future potential for research in Alzheimer's disease.
This book is a valuable resource to academic scientists carrying
out translational research in Alzheimer's disease, industrial
scientists engaged in Alzheimer's drug discovery, executives in
biopharmaceutical companies making strategic decisions regarding
the direction of internal research and potential outside
partnerships, and graduate-level students pursuing courses on
Alzheimer's therapeutics.
In this issue, guest editors bring their considerable expertise to
this important topic. Provides in-depth reviews on the latest
updates in the field, providing actionable insights for clinical
practice. Presents the latest information on this timely, focused
topic under the leadership of experienced editors in the field.
Authors synthesize and distill the latest research and practice
guidelines to create these timely topic-based reviews.
In this issue of Clinics in Geriatric Medicine, guest editor Dr.
David Hunter brings his considerable expertise to the topic of
Osteoarthritis. Top experts in the field cover key topics such as
obesity and nutrition influences in osteoarthritis, the genesis of
pain in osteoarthritis, overview of disease management, and more.
Contains 14 relevant, practice-oriented topics including overview
of disease management, concordance with guidelines, and strategies
to increase implementation of best evidence; obesity and nutrition
influences in osteoarthritis; pathogenesis of osteoarthritis;
behavior change barriers and facilitators in people with
osteoarthritis; suitable candidates and realistic expectations in
surgery for osteoarthritis; and more. Provides in-depth clinical
reviews on osteoarthritis, offering actionable insights for
clinical practice. Presents the latest information on this timely,
focused topic under the leadership of experienced editors in the
field. Authors synthesize and distill the latest research and
practice guidelines to create clinically significant, topic-based
reviews.
In this issue of Child and Adolescent Psychiatric Clinics, guest
editors Drs. Lisa Fortuna, Cheryl S. Al-Mateen, Lisa M. Cullins,
and W. David Lohr bring their considerable expertise to the topic
of Systemic Racism and Disparate Mental Health Outcomes for Youth
of Color. This issue represents a collaboration by American Academy
of Child and Adolescent Psychiatry committee members and includes
contributions by top experts in the field. It is an invaluable
resource for practicing psychiatrists looking to address the unique
needs and experiences of black and BIPOC youth in their practices.
Contains 15 relevant, practice-oriented topics including the
intersection of race and ethnicity with mental health service
utilization in foster care youth; understanding systemic racism and
racial inequity juvenile justice system involvement; racial
disparities in the education system; suicide among minoritized and
marginalized youth; trauma and youth of color; parenting and
family-based care; and more. Provides in-depth clinical reviews on
systemic racism and disparate mental health outcomes for youth of
color, offering actionable insights for clinical practice. Presents
the latest information on this timely, focused topic under the
leadership of experienced editors in the field. Authors synthesize
and distill the latest research and practice guidelines to create
clinically significant, topic-based reviews.
Poor clinical trial designs result in failed studies wasting
research funds and limiting the advancement of cures for disorders.
Clinical Trial Design Challenges in Mood Disorders outlines classic
problems researchers face in designing clinical trials and
discusses how best to address them for the most definitive and
generalizable results. Traditional trial designs are included as
well as novel analytic techniques. The book examines information on
high placebo response, the generalizability of studies conducted in
the developing world, the duration of maintenance studies, and the
application of findings into clinical practice. With representation
from contributors throughout the world and from academia, industry,
regulatory agencies, and advocacy groups, this book will contribute
toward improved clinical trial design and valid, precise, and
reliable answers about what works better and faster for patients.
|
|